Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Acta Pharmaceutica Sinica ; (12): 475-480, 2007.
Artículo en Chino | WPRIM | ID: wpr-268614

RESUMEN

This study is to investigate if madecassoside can protect against myocardial reperfusion injury in rabbit heart in vivo. The ischemia reperfusion model was established. Left ventricular function and ECG were monitored at the ischemia and reperfusion period. The infarct areas were expressed as percentage. The levels of LDH, CK, MDA and SOD were measured and C-reactive protein (CRP) in serum was measured by ELISA kit. Cardiomyocyte apoptosis were measured by TUNEL staining. A monoclonal rabbit anti-goat Bcl-2 proteins as primary antibody was used for Bcl-2 immunohistochemical staining. Treatment with madecassoside (3.2, 1.6 and 0.8 mg x kg(-1)) i.v. during ischemia reperfusion injury attenuated myocardial damage, that is, characteristic of decreasing infarct size, decreasing LDH and CK release. Activities of SOD were diminished and MDA level increased obviously in control group whereas pretreatment with madecassoside significantly blunted the decrease of SOD activity, markedly reduced the levels of MDA, CRP and cardiomyocyte apoptosis, and upregulated the expression of Bcl-2. Madecassoside has the protective effect against myocardial ischemia reperfusion injury, and effects of anti-lipid peroxidation, enhancement of SOD activity, anti-inflammation and anti-apoptosis.


Asunto(s)
Animales , Masculino , Conejos , Apoptosis , Proteína C-Reactiva , Metabolismo , Cardiotónicos , Farmacología , Centella , Química , Creatina Quinasa , Sangre , Electrocardiografía , L-Lactato Deshidrogenasa , Sangre , Peroxidación de Lípido , Malondialdehído , Sangre , Daño por Reperfusión Miocárdica , Metabolismo , Patología , Miocardio , Metabolismo , Patología , Miocitos Cardíacos , Patología , Plantas Medicinales , Química , Proteínas Proto-Oncogénicas c-bcl-2 , Metabolismo , Distribución Aleatoria , Superóxido Dismutasa , Sangre , Triterpenos , Farmacología
2.
Acta Pharmaceutica Sinica ; (12): 1266-1270, 2007.
Artículo en Chino | WPRIM | ID: wpr-268193

RESUMEN

The effect of recombinant microplasmin (micro-plasmin) on acute cerebral infarction was evaluated in rats, and compared with recombinant tissue plasminogen activator (rt-PA). After the model of middle cerebral artery occlusion (MCAO) was established by autologous blood clots, different doses of micro-plasmin (2.5, 5, and 10 mg x kg(-1)) were administered into the thrombus intra-arterial. Twelve hours after administration of micro-plasmin, the neurological deficit score of rats was recorded and the infarct volumes were determined. Bleeding time (BT), fibrin degradation product (FDP) concentration in serum and thrombin time (TT), prothrombin time (PT) and fibrinogen (FIB) concentration in plasma were tested after administration. Intra-arterial administration of micro-plasmin could reduce significantly neurological deficit score and infarct volumes in MCAO rats. FDP concentration increased significantly as compared with model group. There were no significant differences in TT, PT and BT. FIB concentration reduced markedly as compared with model group, but had no significant difference as compared with sham group. The results suggest that micro-plasmin is effective in treatment of rat acute cerebral infarction, and has no significant influence on fibrinolytic system and blood clotting system, indicating that micro-plasmin may be useful for treatment of acute cerebral infarction, and not lead to hemorrhage. Micro-plasmin seems to be distinguished from clinical used rt-PA by its no hemorrhage effect.


Asunto(s)
Animales , Masculino , Ratas , Tiempo de Sangría , Encéfalo , Patología , Hemorragia Cerebral , Metabolismo , Patología , Infarto Cerebral , Quimioterapia , Patología , Productos de Degradación de Fibrina-Fibrinógeno , Metabolismo , Fibrinógeno , Metabolismo , Fibrinolisina , Farmacología , Infarto de la Arteria Cerebral Media , Fragmentos de Péptidos , Farmacología , Tiempo de Protrombina , Distribución Aleatoria , Ratas Sprague-Dawley , Proteínas Recombinantes , Farmacología , Tiempo de Trombina , Activador de Tejido Plasminógeno , Farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA